about
Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives.Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare settingA cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in TaiwanSelf-assessed life expectancy among older adults in Côte d'Ivoire
P50
description
researcher ORCID ID = 0000-0002-6251-0773
@en
wetenschapper
@nl
name
Vakaramoko Diaby
@ast
Vakaramoko Diaby
@en
Vakaramoko Diaby
@es
Vakaramoko Diaby
@nl
type
label
Vakaramoko Diaby
@ast
Vakaramoko Diaby
@en
Vakaramoko Diaby
@es
Vakaramoko Diaby
@nl
prefLabel
Vakaramoko Diaby
@ast
Vakaramoko Diaby
@en
Vakaramoko Diaby
@es
Vakaramoko Diaby
@nl
P31
P496
0000-0002-6251-0773